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The a;-macroglobulin receptor was solubilized from human placental membranes, purified and characterized. Affinity 
cross-linking of labelled ligand to intact membranes howed a receptor size compatible with 40&500 kDa. The mem- 
branes were solubilized in 3-[(3-cholamidopropyl)dimethylammonio]propane sulfonate (CHAPS) and affinity chromatog- 
raphy was performed using Sepharose-immobilized %-macroglobulin-methylamine with elution in buffer containing 2 
mM EDTA, pH 6.0. SDS-PAGE of the resulting receptor preparation showed a predominant approx. 440 kDa band 
(reducing conditions) and some minor accompanying proteins of 7@90 kDa and 40 kDa. The yield was 400-800 pg recep- 
tor preparation per placenta. The receptor preparation immobilized on nitrocellulose bound the q-macroglobulin-trypsin 
complex with a dissociation constant of about 400 pM. 1Z51-iodinated receptor preparation bound almost quantitatively 
to Sepharose-immobilized q-macroglobulin-methylamine in the presence of CHAPS alone, and bound 70-805 in the 
presence of 0.25 SDS. The labelled proteins were separated in the presence of 0.2% SDS by gel filtration or SDS-PAGE 
(unboiled samples). The 440 kDa protein accounted for the major part of the binding, although some approx. 80 kDa 
proteins, perhaps proteolytic degradation products, also showed binding activity. 
Macroglobulin receptor, $-; Placenta; Inhibitor-3, LYE- 
1. INTRODUCTION 
The az-macroglobulin (LYZM) receptor specifical- 
ly binds complexes between CYZM and proteinases, 
whereas native (uncomplexed) cv2M does not. 
Treatment with methylamine also causes the con- 
version of UY~M to a receptor-active form. Previous 
studies have shown that azM receptors are abun- 
dant in rodent [l-3] and human [4] hepatocytes. 
In fact, receptor-mediated endocytosis in 
hepatocytes largely accounts for the rapid removal 
(ti/z about 2 min) of the cuzM-trypsin complex 
&MT) in the rat [5]. Recently, the CQM receptor 
was identified as a high molecular weight protein 
in solubilized rat liver membranes [6] and subse- 
quently purified by affinity chromatography as an 
approx. 440 kDa single-chain protein 171. 
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We have previously shown [8] that human 
placental membranes contain large quantities of 
CQM receptor with affinities for the human (YzM- 
proteinase complex and the homologous pregnan- 
cy zone protein-proteinase complex similar to 
those described in rat and human hepatic mem- 
branes [6]. This communication describes the 
preparation of the placental LYZM receptor. We 
show that the human placental receptor has the 
same size as the rat hepatic receptor and that bin- 
ding activity is preserved in the purified placental 
receptor protein. 
2. MATERIALS AND METHODS 
2.1. Ligands 
Human WZM was prepared from citrate plasma as described 
previously [9] and iodinated to a specific activity of about 
0.5 mol ‘25I (Amersham, UK) per mol (YZM using chloramine-T 
as the oxidizing agent [Z]. Receptor-active a2M was generated 
either by incubation for 5 min at 20°C with a 5 times molar ex- 
cess trypsin followed by soybean trypsin inhibitor (yielding 
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azMT 121) or by incubation with 200 mM methylamine for 2 h 
at 20°C followed by dialysis. 0.9-1.0 mol of titrable SH groups 
were generated by both procedures [9]. Rat al-inhibitor-3 
(cuils), a 200 kDa homologue of the 180 kDa a2M subunit 
which binds to the rat hepatic (YZM receptor [6,11], was 
prepared [11,12], iodinated and incubated with an equimolar 
concentration of chymotrypsin as described previously [6,7]. 
2.2. Membranes 
Placental membranes were prepared essentially as described 
[8]. In brief, pieces (l-2 g) of villous tissue were washed in ice- 
cold phosphate-buffered saline and either frozen in liquid 
nitrogen or homogenized irectly at 0°C in 120 ml of 250 mM 
sucrose, 10 mM Hepes, 5 mM EDTA, 0.1 mM phenylmethane- 
sulfonyl fluoride (PMSF), pH 7.4 (45 s, 80 g wet tissue) using 
an ULTRA-TURRAX with a 525KG-256 head. Debris was 
removed by centrifugation first at 600 x g for 3 min, then at 
3000 x g for 5 min. The supernatant was centrifuged at 48000 
x g for 40 min and the membrane pellet rehomogenized in 
140 mM NaCl, 0.6 mM CaCl2, 10 mM Na-phosphate, 0.1 mM 
PMSF, pH 7.8. The membranes were again centrifuged at 
48000 x g for 40 min and resuspended in the above buffer to 
a concentration of about 6 mg protein/ml. The yield from 80 g 
wet tissue was about 500 mg membrane protein (1.0-l .2 g per 
placenta). The membranes were either stored at -20°C or 
solubilized directly. 
2.3. Affinity chromatography 
8-10 mg cuzM-methylamine was coupled to about 1.2 g 
CNBr-activated Sepharose 4B (Pharmacia LKB Biotechnology, 
Sweden) according to the manufacturers’ recommendations. 
The membranes (6 mg protein/ml) were solubilized by the addi- 
tion of 3-[(3-cholamidopropyl)dimethylammonio]-l-propane 
sulfonate dihydrate (CHAPS, Aldrich, FRG) to 1%. The 
suspension was stirred for 10 min at 0°C followed by cen- 
trifugation for 40 min at 48000 x g and incubation of the 
supernatant with the affinity gel for 18 h at 4°C. The gel was 
poured onto a column (bed volume about 4 ml) and washed ex- 
tensively with 140 mM NaCl, 0.6 mM CaCl2, 10 mM Na- 
phosphate, 1% CHAPS, pH 7.8. The receptor protein was 
eluted by reducing pH to 6.0 and adding EDTA to 2 mM. The 
eluted receptor preparation (4 pg protein) was iodinated by in- 
cubation for 3 min with 0.2 mCi ‘2511 and 16pg/ml 
chloramine-T in buffer containing 0.1% CHAPS, pH 8.0 (final 
volume 55 pl), followed by filtration on Sephacryl S-306 to 
remove ‘251- and minor degradation products. Incorporation of 
“‘1 into protein was about 50%. 
Rat liver membranes were prepared, solubilized and sub- 
jected to affinity chromatography as described previously [6,7]. 
2.4. Assays for ligand binding 
Incubations (300,4g membrane protein/ml) were performed 
in 140 mM NaCl, 0.6 mM CaCl2, 10 mM Na-phosphate, 1% 
bovine serum albumin, pH 7.8, for 18 h at 0°C. The mem- 
branes were pelleted by centrifugation in microfuge tubes [8]. 
Cross-linking of ‘251-~iIr-chymotrypsin was performed essen- 
tially as described for rat hepatic membranes using disuc- 
cinimidyl suberate (DSS), cf. legend to fig. 1. Dot blot assay of 
the receptor protein eluted from the affinity column was per- 
formed as follows. Receptor solution (4~1) was applied to 
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Fig. 1. Cross-linking of ‘251-criIs-chymotrypsin to placental 
membranes. Membranes (300 pg protein/ml) were incubated 
for 18 h at 4°C with about 20 pM ‘251-~J~-chymotrypsin in the 
absence (open and hatched bars) or presence (filled bars) of 
200 nM unlabelled a2MT. DSS dissolved in DMSO was added 
to 0.2 mM and the incubation continued for 10 min (hatched 
and filled bars). The open bars (heavy line) show the result of 
the addition of DMSO only. The membranes were layered upon 
60 mM Tris-HCl, 5% glycerol, pH 6.8, pelleted and dissolved 
in 200 ml of 5% SDS sample buffer. The samples were 
centrifuged at 100000 x g for 15 min followed by SDS-PAGE. 
The dried gel was sliced and pieces of about 4 mm were counted 
for radioactivity. 
nitrocellulose discs (Sartorius, FRG, diameter 5 mm) and dried 
at 4°C followed by incubation at 4°C for 1 h in the NaCI- 
CaClr-phosphate-CHAPS buffer with 1% bovine serum 
albumin followed by the addition of “‘1-ryzMT with or without 
unlabelled ~Y~MT and incubation for 18 h. The discs were then 
washed in 3 x 1.5 ml ice-cold buffer and counted. About 0.7% 
of the “‘I-(uzMT was associated with the filter when the pro- 
cedure was performed with discs dotted with eluate not contain- 
ing receptor protein and the same value was obtained when 
discs with receptor were incubated with a saturating concentra- 
tion of unlabelled ~zMT, cf. fig.3. 
The ‘2sI-labelled receptor preparation was incubated with 
about 100 nM Sepharose-immobilized cuzM-methylamine. 
Sepharose-bound and unbound radioactivity was separated by 
centrifugation followed by four times wash in buffer at 0°C. 
The blank value was determined as the radioactivity associated 
with Sepharose-azM-methylamine in the presence of 2 mM 
EDTA (about 2%) and was subtracted from all measurements. 
2.5. Other methods 
Protein concentrations were determined according to Brad- 
ford [13] using bovine serum albumin as a standard. 
SDS-PAGE with 4-8% or 8-16% polyacrylamide gradients 
was performed according to Laemmli [14] using 80 mm long, 
0.4 mm thick slab gels. Molecular size markers were for non- 
reduced samples: cross-linked a2M [6], 720 kDa; CQM, 
360 kDa; r~iI3, 200 kDa; and for reduced samples: laminin, 
heavy chain 400 kDa; light chains 220 and 210 kDa [7,15]; and 
low molecular weight markers from Pharmacia, Sweden. 
Autoradiography of the *ZSI-labelled receptor preparation was 
carried out on dried gels using preflashed Hyperfilm MP 
(Amersham, UK) with exposure between enhancing screens at 
- 80°C. 
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3. RESULTS 123 456 78 9 
We first tested that rat a&chymotrypsin was 
bound to the ~zM receptors in human placental 
membranes as previously shown for rat and human 
hepatic membranes (61. Table 1 shows that 20 pM 
‘251-labelled cr&chymotrypsin was bound nearly 
as well as labelled human cuzM-trypsin and that 
binding of both labelled ligands was almost entire- 
ly inhibited by a saturating concentration of CYZM- 
trypsin. The addition of 2 mM EDTA abolished 
the binding within 10 min. Thus, cu&-chymotryp- 
sin binds to the placental ~zM receptors with an af- 
finity of the same magnitude as those of human 
LY~M or pregnancy zone protein complexes [8]. 
Fig.1 shows the electrophoretic migration of 
1251-labelled ~~113 cross-linked to placental mem- 
branes followed by solubilization. The binding to 
the membranes in the absence of cross-linker is 
shown by the open bars (heavy line). The radioac- 
tive material migrates corresponding to a protein 
of about 200 kDa since ~~I~-ch~ot~sin 
dissociates from the receptor in SDS. An addi- 
tional peak not distinguishable from a protein of 
about 700 kDa appears when the labelled ligand is 
cross-linked to the membranes (hatched bars). The 
ligand therefore binds to a large molecule compati- 
ble with a 400-500 kDa receptor protein. The fill- 
ed bars show that the large MW species is absent 
when the membranes are incubated with 1251- 
cu&chymotrypsin plus a saturating concentration 
of unlabelled cv2MT and cross-linked. 
Mr 
94 
67 
43 
21 
The placental membranes were solubilized in 1% 
CHAPS and applied to affinity chromatography 
Table 1 
Binding of ~113-ch~otrypsin to human placental membranes 
Fig.2. SDS-PAGE of affinity-purified placental (YZM receptor 
preparation. (Upper panel) 4-8% polyacrylamide. Lanes l-6, 
non-reduced samples; lanes 7-9, reduced samples. Lanes: 1, 
CXZM half molecule (360 kDa); 2, eluate before the pH shift; 
3-6, samples (40 ~1) of 1 .O ml fractions eluted consecutively; 7, 
reduced eluted protein; 8, reduced laminin (heavy chain 
400 kDa, light chains, 220 and 210 kDa); 9, reduced rat hepatic 
receptor. (Lower panel) 8-16% polyacrylamide. (Left) About 
20 pg non-reduced placental LYZM receptor preparation; (right) 
Tracer alone Plus 100 nM Plus 2 mM 
azMT EDTA 
‘ZSI-a,I,-chy 11.2 + 0.9 0.6 f 0.1 0.9 + 0.2 
‘2fI-rurMT 16.1 + 1.3 0.4 f 0.1 0.7 rt 0.1 
The incubations (3OOpg membrane protein/ml) were carried 
out for 18 h with 20 pM “ZSI-labelled cY&chymotrypsin or 
a2MT. Unla~ll~ atMT, when present, was added together 
with the tracer. EDTA was added to 2 mM after 18 h followed 
by further incubation for 10 min. The numbers represent 
membrane-bound tracer as a % of the total tracer added, 
mean f t SD, n = 4 
molecular size markers. Stain, Coomassie brilliant blue. 
using Sepharose-immobilize ~2M-methylamine. 
Fig.2, upper panel, shows the results using SDS- 
PAGE. Lanes l-6 represent non-reduced samples. 
Lane 1 shows human azM used as a molecular size 
marker. Lane 2 illustrates the absence of protein in 
the column eluate before the shift to elution buffer 
with 2 mM EDTA, pH 6.0. The eluted receptor 
preparation is seen in lanes 3-6 with the pH shift 
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corresponding to lane 3. The non-reduced large 
receptor protein shows a slightly slower migration 
than the 360 kDa azM half molecule as previously 
shown for the rat hepatic CQM receptor [7]. Dot 
blot assay (not demonstrated) showed that azMT- 
binding activity coeluted with the large protein as 
previously shown for the rat hepatic receptor 
preparation [7]. The yield was 150-300 pg large 
protein per 500 mg solubilized placental mem- 
brane protein. 
Lane 7 shows that reduction of the crzM receptor 
preparation caused a decreased mobility of the 
large receptor protein with an estimated size of 
about 440 kDa when using reduced laminin as a 
standard (lane 8). This apparent size is not 
distinguishable from that previously determined 
[7] for the reduced rat hepatic receptor displayed in 
lane 9. 
Fig.2, lower panel, shows a 8-16% polyacryl- 
amide gel, overloaded with regard to the 440 kDa 
protein to show the presence of some minor 
coeluting proteins. A distinct band is seen at about 
40 kDa and a smear at 70-90 kDa. 
Fig.3 shows that the receptor preparation eluted 
from the affinity column and immobilized on 
nitrocellulose bound 12SI-labelled a2MT. The bin- 
ding was abolished by 500 nM unlabelled a2MT 
and the apparent & was estimated as about 
400 pM (inset). Thus, the cu2MT-binding affinity 
of the human placental receptor preparation is 
similar to that of the rat hepatic receptor [7]. 
The following experiments were performed to 
ascertain that the 440 kDa protein was the binding 
species. Preliminary experiments (not demon- 
strated) showed that the receptor preparation 
chromatographed as a single peak in buffer with 
1% CHAPS on Sephacryl S-300. On the other 
hand, separation of the minor proteins from the 
440 kDa species was achieved in the presence of 
2% SDS, but binding activity was abolished. We 
therefore labelled the receptor preparation in the 
presence of 1 Vo CHAPS. The labelled preparation 
was almost quantitatively bound to Sepharose- 
immobilized azM-methylamine and increasing 
concentrations of SDS caused a progressive 
decrease of the binding (not shown). Binding of 
the labelled receptor preparation was about 80% 
when SDS was added to 0.2%. 
Fig.4, upper panel, shows that a partial separa- 
tion was achieved when the labelled receptor 
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Fig.3. wMT binding to nitrocellulose-immobilized azM 
receptor preparation. The nitrocellulose discs with about 70 ng 
LYZM receptor preparation were incubated for 18 h at 4°C with 
15 pM ‘251-labelled c-QMT and total CY~MT concentrations as 
indicated. The inset shows a Scatchard plot of the same data 
after subtraction of the B/F value at 500 nM (Y~MT. The 
apparent & was calculated as 413 pM. 
preparation was chromatographed on Sephacryl 
S-300 in the presence of 0.2% SDS. The peak frac- 
tion (A) showed 72% binding to Sepharose- 
methylamine, whereas only 4-5070 of the shoulder 
fraction (B) was bound. Fig.4, lower panel, shows 
autoradiograms of gels performed with samples 
(not boiled) of fractions A and B with 0.2% SDS. 
Lanes 1 and 3 show that 85-90% of the radioac- 
tivity in fraction A was in the 440 kDa band and 
lo- 15% in an approx. 80 kDa band corresponding 
to the 70-90 kDa smear shown in fig.2B. This 
shows that he 440 kDa protein accounts for the 
major part of the binding activity of fraction A. 
Lanes 2 and 4 show that fraction B had about 10% 
of the radioactivity in the approx. 80 kDa band 
and about 90% in the 40 kDa band. 
We attempted to obtain more direct data by ex- 
tracting the labelled proteins into buffer contain- 
ing 1% CHAPS from the wet gel slices run in 
parallel to the gels used for autoradiography. The 
440 kDa protein bound 15.2 -+ 0.5% (n = 3). Thus, 
the SDS-PAGE and extraction procedure had 
reduced the ability of the molecules to bind to 
azM-methylamine. The approx. 80 kDa proteins 
also bound, although to a varying degree (6-16% 
in three experiments), whereas the 40 kDa protein 
did not bind. 
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Fig.4. Separation of the 1Z51-labelled cu2M receptor preparation in the presence of 0.2Vo SDS. (Upper panel) Sephacryl S-300 
chromatography in 140 mM NaCl, 0.6 mM CaC12, 10 mM Na-phosphate, 1% CHAPS, 0.2% SDS, pH 8.0. The numbers show the 
Vo radioactivity of fractions A or B bound to 100 nM Sepharose-immobilized cuzM-methylamine (n = 3). (Lower panel) 
Autoradiograms (PAGE: 0.2% SDS, unboiled, non-reduced samples) of fractions A and B. The numbers between lanes indicate 
molecular sizes (kDa) of the radioactive bands. The underlined numbers show the radioactivity in each of the bands, expressed as ‘70 
of total radioactivity in the lane. The numbers were determined by counting slices of the dried gel. 
4. DISCUSSION 
The conclusion that the 440 kDa protein is an 
azM receptor is based on the following findings. (i) 
Affinity cross-linking of the c&-chymotrypsin 
complex to intact membranes is compatible with a 
400-500 kDa receptor. (ii) The 440 kDa species is 
by far the dominating protein of the affinity- 
purified receptqr preparation with preserved bind- 
ing affinity. (iii) Binding of radiolabelled receptor 
preparation to Sepharose-immobilized a2M- 
methylamine is largely accounted for by the 
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440 kDa protein. These results are similar to those 
previously described for the rat hepatic CYZM recep- 
tor [7]. 
The origin of the co-purifying minor proteins is 
uncertain. The simplest explanation is perhaps that 
they are proteolytic products which bind non- 
covalently to the 440 kDa receptor in the absence 
of SDS. If so, the 40 kDa fragment does not con- 
tain the ligand-binding domain, whereas one or 
more of the 70-90 kDa fragments do. However, it 
cannot be excluded that the 70-90 kDa proteins 
represent low molecular weight receptors. If so, 
they appear quantitatively unimportant as judged 
both from the cross-linking experiments to placen- 
tal membranes (fig.2) and their low content in the 
affinity-purified receptor preparation (fig.3). The 
approx. 440 kDa protein is therefore the major 
and perhaps the only placental a2M receptor. 
In summary, the human placental cvzM receptor 
has been purified as an approx. 440 kDa single- 
chain protein with, at least partially, preserved 
ligand-binding activity. The affinity-purified 
receptor preparation contains traces of minor, ac- 
companying proteins, perhaps proteolytic 
degradation products, and at least one of the 
70-90 kDa proteins can bind to the ligand. 
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